News
H-D Feminine Health, announces it has initiated the first randomized, placebo-controlled, double-blinded Phase 3 clinical trial cleared to proceed by the U.S. Food and Drug Administration (FDA) to ...
Nigerian Exchange Group (NGX Group), Health Emergency Initiative (HEI) and Lagos State Government have launched a joint ...
Monopar Therapeutics Inc. ('Monopar” or the 'Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, ...
Monopar Therapeutics Inc. ("Monopar" or the "Company") (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments ...
New federally funded research on the relationship between post-traumatic stress disorder and cannabis use in military ...
Tividenofusp alfa BLA for Hunter syndrome accepted for priority review and assigned PDUFA target action date of January 5, 2026; company preparing for commercial launchDNL126 accelerated approval path ...
Clinical Trials of Budoprutug in Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE) Underway; ...
Billy Bragg will host 'Days Like These', a special benefit concert for Amos Trust's Gaza appeal at the O2 Shepherd's Bush Empire in London on Saturday 20 September.
A phase 3 study shows Cylembio combined with pembrolizumab improves progression-free survival in advanced melanoma, ...
Psychedelics are increasingly being studied as wonder medicines for psychiatric issues like depression and even addictions to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results